New cancer drug enters human testing
Disease control
Not yet recruiting
This early-stage study is testing a new drug called LRK-4189 to see if it is safe and might help treat advanced solid tumors, especially colorectal cancer. About 120 adults with cancer that has spread or cannot be removed by surgery will take the drug alone or combined with stand…
Phase: PHASE1, PHASE2 • Sponsor: LARKSPUR BIOSCIENCES, INC. • Aim: Disease control
Last updated Apr 02, 2026 00:41 UTC